Neuberger Berman Group LLC Vanda Pharmaceuticals Inc. Transaction History

Neuberger Berman Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$18.97 - $31.47 $863,135 - $1.43 Million	-45,500 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $282,875 - $356,500	15,500 Added 51.67%	45,500 $1.04 Million
Q2 2018 Aug 13, 2018	BUY	$13.95 - $19.15 $418,500 - $574,500	30,000 New	30,000 $572,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.